Sartorius Stedim Biotech SA - Company Profile
Powered by 
All the sales intelligence you need on Sartorius Stedim Biotech SA in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Sartorius Stedim Biotech SA fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Sartorius Stedim Biotech SA.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Sartorius Stedim Biotech SA (SSB), a subsidiary of Sartorius AG, is a supplier of equipment and services to biopharmaceutical companies. It offers integrated solutions covering filtration, fermentation, fluid management, purification, and cell cultivation. Its major products include laboratory balances, OEM weigh cells, mass comparators, lab water accessories, pipettes, moisture analyzers, bioreactors, filters, chromatography consumables among others. The company also offers a complete range of services from conceptual design, contract testing & research, and detailed engineering. It services includes bioprocess consulting & engineering, cell culture media services, biologics testing, instrument service, validation service and biologics contract services. The company’s products find application in the production process of medicines in biopharmaceutical and pharmaceutical industries. SSB sells products through direct sales force in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. SSB is headquartered in Aubagne, Provence - Alpes- Cote d'Azur, France.
Headquarters
France
Address
Avenue De Jouques, Zone Industrielle Les Paluds, Aubagne, Provence - Alpes- Cote d'Azur, 13400
Telephone
33 4 42845600
No of Employees
10,265
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
DIM (EPA)
Revenue (2024)
$3.3B
6.7%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
51.7%
(2024 vs 2023)
Market Cap*
$20.3B
Net Profit Margin (2024)
XYZ
42.1%
(2024 vs 2023)
* As of and is in US$
Sartorius Stedim Biotech SA premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| BLI Support & Consumables: | Bioprocess Consulting & Engineering | Cubis |
| CellCelector Instruments | Cell Culture Media Services | Unisart |
| CellCelector Software | Biologics Testing | Incucyte |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Corporate Changes/Expansions | In May, the company opened a new competence center for the development and production of quality-critical materials for the cell and gene therapy market. |
| 2025 | Contracts/Agreements | In November, the company collaborated with Aber Instruments to integrate Aber’s BioPAT Viamass single‑use biomass sensor into Sartorius’ Ambr 250 single‑use bioreactors. |
| 2025 | Contracts/Agreements | In July, the company signed a partnership with Bio Usawa Biotechnology to speed up Africa’s biopharmaceutical industry and address the continent’s urgent. |
Competitor Comparison
| Key Parameters | Sartorius Stedim Biotech SA | Thermo Fisher Scientific Inc | Danaher Corp | Merck KGaA | Agilent Technologies Inc |
|---|---|---|---|---|---|
| Headquarters | France | United States of America | United States of America | Germany | United States of America |
| City | Aubagne | Waltham | Washington | Darmstadt | Santa Clara |
| State/Province | Provence - Alpes- Cote d'Azur | Massachusetts | WashingtonD.C. | Hessen | California |
| No. of Employees | 10,265 | 125,000 | 58,000 | 62,136 | 17,900 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Michael Grosse | Chairman | Executive Board | 2025 | 58 |
| Rene Faber | Chief Executive Officer; Director | Executive Board | 2023 | 50 |
| Abdelatif Zeroual | Director - Employees; Director | Executive Board | 2026 | 41 |
| Alexandra Gatzemeyer | Head - Lab Products & Services Division | Senior Management | 2023 | 47 |
| Cecile Dussart | Director | Non Executive Board | 2025 | 61 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer